• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 2 - The Effects of Health Reform on Treatment of Hepatitis C

Article

In this clip, the panel discusses the implications of health reform on the treatment of hepatitis C virus (HCV), including what is needed to improve outcomes. This includes educating primary care physicians about how the Affordable Care Act requires health plans to pay for the costs of testing and screening for risk factors of HCV.

In this clip, the panel discusses the implications of health reform on the treatment of hepatitis C virus (HCV), including what is needed to improve outcomes. This includes educating primary care physicians about how the Affordable Care Act requires health plans to pay for the costs of testing and screening for risk factors of HCV. Screening is recommended for those at risk, including those who have used injection drugs.

However, changes won’t occur overnight, and the recommendations have not yet been implemented by all health plans, nor have they been for all ages (eg, those born between1946-1964). Additionally, unlike many other screening tests, the HCV antibody tests are not as expensive as other screening tests such as mammographies or colonoscopies. In some cases, it’s what the patients do with the information post-screening that matters most.

Related Videos
Dr Chris Pagnani
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Binod Dhakal, MD
Screenshot of Joshua Meeks, MD, PhD, during a video interview
Screenshot of Yuzhi Wang, MD, in a video interview
Screenshot of Neal Shore, MD, in a video interview
Dr Chris Pagnani
Screenshot of Ryan Nix, PharmD, during a video interview
Amit Singal, MD, UT Southwestern Medical Center
Rashon Lane, PhD, MA
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.